Report of the Committee of the Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus: New Diagnostic Criteria of Fulminant Type 1 Diabetes Mellitus (2012)
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Intensive insulin therapy is effective in preventing the onset of macroangiopathy in type 2 diabetes.
“Intensive insulin therapy has been shown to be effective in preventing the onset of macroangiopathy in type 2 diabetes 9 , 31 , 32 .”
From Japanese clinical practice guideline for diabetes 2019 (2020) · cites this paper as [9]
Blood pressure control is useful for suppressing the onset/progression of diabetic retinopathy in patients with type 2 diabetes.
“Blood pressure control has been shown to be useful for suppressing the onset/progression of diabetic retinopathy in patients with type 2 diabetes 9 , 10 , 11 (grade A: 100% agreement).”
From Japanese clinical practice guideline for diabetes 2019 (2020) · cites this paper as [9]
SMBG is useful for patients with type 1 diabetes.
“SMBG has been shown to be useful for patients with type 1 diabetes 9 , 10 , 11 and for patients with type 2 diabetes receiving insulin therapy 12 (grade A: 95% agreement).”
From Japanese clinical practice guideline for diabetes 2019 (2020) · cites this paper as [9]
Foot care is effective for preventing foot ulcers or limb salvage in high-risk patients.
“Foot care is shown to be effective for preventing foot ulcers or limb salvage in high‐risk patients 8 , 9 . [grade A: 100% agreement]”
From Japanese clinical practice guideline for diabetes 2019 (2020) · cites this paper as [9]
Modification of lifestyle habits and correction of obesity are associated with amelioration of risk factors for cardiovascular events in patients with diabetes.
“The modification of lifestyle habits and the correction of obesity are recommended in patients with diabetes, given that these measures are shown to be associated with the amelioration of these risk factors 7 , 8 , 9 (grade A: 90% agreement).”
From Japanese clinical practice guideline for diabetes 2019 (2020) · cites this paper as [9]
Physical activity/exercise is effective against dyslipidemia in patients with diabetes.
“Physical activity/exercise has been shown to be effective against dyslipidemia in patients with diabetes 9 , 10 (grade A: 100% agreement).”
From Japanese clinical practice guideline for diabetes 2019 (2020) · cites this paper as [9]
Dietary modification aimed at ensuring an optimal total energy intake plays an important role in preventing type 2 diabetes.
“Dietary modification aimed at ensuring an optimal total energy intake plays an important role in preventing type 2 diabetes 8 , 9 , 10 .”
From Japanese clinical practice guideline for diabetes 2019 (2020) · cites this paper as [9]
A 2 kg weight loss with lifestyle modification is associated with a reduced risk of type 2 diabetes.
“A 2 kg weight loss with lifestyle modification is associated with a reduced risk of type 2 diabetes 8 , 9 , 10 .”
From Japanese clinical practice guideline for diabetes 2019 (2020) · cites this paper as [9]
Cites
Kashiwagi, A., Kasuga, M., Araki, E., Oka, Y., Hanafusa, T., Ito, H., Tominaga, M., Oikawa, S., Noda, M., Kawamura, T., et al. (2012) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2012.00207.x · Cited by 902 · see citing works
Self-citationImagawa, A., Hanafusa, T., Miyagawa, J., & Matsuzawa, Y. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002033420501 · Cited by 653 · see citing works
Self-citationImagawa, A., Hanafusa, T., Uchigata, Y., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2345 · Cited by 293 · see citing works
Self-citationImagawa, A., Hanafusa, T., Awata, T., et al. (2012) · Journal of Diabetes Investigation · doi:10.1111/jdi.12024 · Cited by 249 · see citing works
Self-citationKashiwagi, A., Kasuga, M., Araki, E., Oka, Y., Hanafusa, T., Ito, H., Tominaga, M., Oikawa, S., Noda, M., Kawamura, T., et al. (2012) · Diabetology International · doi:10.1007/s13340-012-0069-8 · Cited by 213 · see citing works
Self-citationKawabata, Y., Ikegami, H., Awata, T., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1539-9 · Cited by 170 · see citing works
Self-citationClinical and Immunogenetic Characteristics of Fulminant Type 1 Diabetes Associated with Pregnancy
Shimizu, I., Makino, H., Imagawa, A., Iwahashi, H., Uchigata, Y., Kanatsuka, A., Kawasaki, E., Kobayashi, T., Shimada, A., Maruyama, T., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1943 · Cited by 86 · see citing works
Self-citationTsutsumi, C., Imagawa, A., Ikegami, H., et al. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2011.00139.x · Cited by 82 · see citing works
Self-citationType 1 Diabetes and Interferon Therapy
Nakamura, K., Kawasaki, E., Imagawa, A., Awata, T., Ikegami, H., Uchigata, Y., Kobayashi, T., Shimada, A., Nakanishi, K., Makino, H., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2274 · Cited by 68 · see citing works
Self-citationKoga, M., Murai, J., Saito, H., Kasayama, S., Imagawa, A., Hanafusa, T., & Kobayashi, T. (2010) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2010.009234 · Cited by 41 · see citing works
Self-citationImagawa, A., Hanafusa, T., Iwahashi, H., et al. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.08.003 · Cited by 20 · see citing works
Self-citationTakaike, H., Uchigata, Y., Iwamoto, Y., et al. (2008) · Annals of Medicine · doi:10.1080/07853890802032711 · Cited by 14 · see citing works
Self-citationDifferent contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus
Imagawa, A., Hanafusa, T., Uchigata, Y., et al. (2008) · Diabetologia · doi:10.1007/s00125-007-0906-7 · Cited by 6 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Japanese clinical practice guideline for diabetes 2019
Araki, E., Goto, A., Kondo, T., Noda, M., Noto, H., Origasa, H., Osawa, H., Taguchi, A., Tanizawa, Y., Tobe, K., et al. (2020) · Diabetology International · doi:10.1007/s13340-020-00439-5 · Cited by 545 · see citing works
Self-citationKawasaki, E., Maruyama, T., Imagawa, A., Awata, T., Ikegami, H., Uchigata, Y., Osawa, H., Kawabata, Y., Kobayashi, T., Shimada, A., et al. (2013) · Diabetology International · doi:10.1007/s13340-013-0122-2 · Cited by 19 · see citing works
Self-citation
- Authors
- Imagawa, A., Hanafusa, T., Awata, T., Ikegami, H., Uchigata, Y., Osawa, H., Kawasaki, E., Kawabata, Y., Kobayashi, T., Shimada, A., Shimizu, I., Takahashi, K., Nagata, M., Makino, H., & Maruyama, T.
- Affiliations
- The University of Osaka (JP)
- Osaka Medical and Pharmaceutical University (JP)
- Saitama Medical University (JP)
- Kindai University (JP)
- Tokyo Women's Medical University (JP)
- Ehime University Hospital (JP)
- Nagasaki University Hospital (JP)
- University of Yamanashi (JP)
- Saiseikai Central Hospital (JP)
- Sakakibara Hospital (JP)
- Iwate Medical University (JP)
- Kakogawa City Hospital Organization (JP)
- Social Insurance Saitama Chuo Hospital (JP)
- Corresponding author
- Hanafusa, Toshiaki
- ORCID
- Venue
- Diabetology International
- Published
- 2012-11-22
- Volume
- 3
- Issue
- 4
- Pages
- 179-183
- ISSN
- 2190-1678 (ISSN-L)
- 2190-1686
- OpenAlex
- W4244323884
- Cited by
- 29
- References
- 13
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 4 · 2021: 4 · 2020: 4 · 2019: 2 · 2018: 1 · 2017: 1 · 2016: 1 · 2013: 2 · 2012: 1
- FWCI
- 0.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetology International (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (24591346, 23591328, 24591362)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- fulminant type 1 diabetes, diagnostic criteria, HbA1c, hyperglycemia, HLA-DRB1*0405, screening criteria, impaired glucose tolerance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
